Dolutegravir Sodium

CAS 1051375-19-9 19 current recordsSmall Molecule

Who holds supplier records for Dolutegravir Sodium? 19 organisations hold a current record for Dolutegravir Sodium: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (14), China (3) and Slovenia (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Dolutegravir Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/dolutegravir-sodium

Reading the evidence

  • 19 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    14 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (19)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dolutegravir Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India14China3Slovenia1Country not recorded for 1
Need Dolutegravir Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dolutegravir Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1213165).

Chemical identity

IUPAC name
sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
Canonical SMILES
C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
InChIKey
UGWJRRXTMKRYNK-VSLILLSYSA-M
Synonyms
Dolutegravir sodium, Dolutegravir sodium component of dovato, Dolutegravir sodium component of juluca, Dolutegravir sodium component of triumeq, Dolutegravir sodium salt, Dovato, GSK-1349572A, GSK1349572A, Tivicay, Tivicay pd, CHEBI:76007, JULUCA COMPONENT DOLUTEGRAVIR SODIUM

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Mechanism of action
HIV Integrase Inhibitors; Multidrug and Toxin Extrusion Transporter 1 Inhibitors; Organic Cation Transporter 2 Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dolutegravir Sodium?

19 organisations hold an active US FDA Type II Drug Master File or a CEP for Dolutegravir Sodium: Laurus Labs Limited (India), Cipla Limited (India), Hetero Labs Limited (India), LUPIN MANUFACTURING SOLUTIONS LTD, MATRIX PHARMACORP PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), APITORIA PHARMA PRIVATE LTD (India) and Arene Life Sciences Limited (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dolutegravir Sodium Drug Master Files are active?

Laurus Labs Limited (DMF 33768, 39678), Cipla Limited (DMF 30055, 31107), Hetero Labs Limited (DMF 32955, 30544), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 31472, 31473), MATRIX PHARMACORP PRIVATE LTD (DMF 31209, 30011), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 31243, 36999), APITORIA PHARMA PRIVATE LTD (DMF 28721) and Arene Life Sciences Limited (DMF 34471) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Dolutegravir Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dolutegravir Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.